Clesrovimab (MK-1654), an Investigational RSV Monoclonal Antibody, Significantly Reduced Incidence of RSV Disease and ...

Clesrovimab scored on several endpoints, showing an ability to protect infants against the virus in their first RSV season.

Merck said on Thursday its experimental antibody therapy, clesrovimab, demonstrated a 60.4% effectiveness in reducing ...

Germany stocks were higher after the close on Thursday, as gains in the Pharmaceuticals & Healthcare, Industrials and ...

Merck KGaA said its doors are open for more M&A, particularly for its manufacturing business, as the company tempers sales ...

German science and technology group Merck is open to more acquisitions for its Life Science business after announcing in May ...

Shares of Merck KGaA surged after the company confirmed its outlook for fiscal year 2024 and revisions to its mid-term sales ...

Iktos appoints new Scientific Advisory Board with world-renowned AI and Drug Discovery experts to accelerate the development of novel therapies Paris (France), 17 October, 2024 – Iktos, a leader in ...

German stocks traded higher on Thursday as investors digested a slew of earnings and awaited an interest rate cut by the European ...

The German company said booming artificial-intelligence demand would help its electronics sales grow faster than previously ...

Merck KGaA cut its mid-term sales growth target for its health-care division after a number of high-profile drug trial ...

Merck KGaA lowered its medium-term outlook for its healthcare and life-science segment due to China challenges and recent ...